TESICO (NCT04843761)

TESICO (Therapeutics for Severely Ill Inpatients with COVID-19) is a master protocol to evaluate the safety and efficacy of investigational agents aimed at improving outcomes for patients with acute respiratory failure related to COVID-19.

PI: Emerson Perin, MD

SPONSOR: National Institute of Allergy and Infectious Diseases (NIAID)

TESICO-annotated-FLIPBOOK